Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 9, 2000 - Issue 11
Submit an article Journal homepage
72
Views
19
CrossRef citations to date
0
Altmetric
Review

Novel lipid-regulating drugs

Gilbert R Thompson Division of Investigative Science, Imperial College School of Medicine and MRC Molecular Medicine Group, MRC Clinical Sciences Centre, Hammersmith Hospital, London, UK. [email protected]
&
Rossi P Naoumova Division of Investigative Science, Imperial College School of Medicine and MRC Molecular Medicine Group, MRC Clinical Sciences Centre, Hammersmith Hospital, London, UK. [email protected]
Pages 2619-2628 | Published online: 23 Feb 2005

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Eli E Bar & Duncan Stearns. (2008) New developments in medulloblastoma treatment: the potential of a cyclopamine–lovastatin combination. Expert Opinion on Investigational Drugs 17:2, pages 185-195.
Read now

Articles from other publishers (18)

Elina Sievänen. (2007) Exploitation of Bile Acid Transport Systems in Prodrug Design. Molecules 12:8, pages 1859-1889.
Crossref
Ramakrishna Nirogi, Koteshwara Mudigonda & Vishwottam Kandikere. (2007) Chromatography–mass spectrometry methods for the quantitation of statins in biological samples. Journal of Pharmaceutical and Biomedical Analysis 44:2, pages 379-387.
Crossref
Antara Banerjee, Jeffrey S. Johnston & Peter W. Swaan. 2004. Cellular Drug Delivery. Cellular Drug Delivery 107 128 .
Holger Stark. (2003) Medizinisch‐chemische Aspekte von Statinen: Wirkmechanismus von HMG‐CoA‐Reduktase‐Inhibitoren. Pharmazie in unserer Zeit 32:6, pages 464-470.
Crossref
M A Morgan, A Ganser & C W M Reuter. (2003) Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia. Leukemia 17:8, pages 1482-1498.
Crossref
Omer L. Shedd & Marian C. Limacher. (2003) Prevention of cardiovascular disease in women. Current Treatment Options in Cardiovascular Medicine 5:4, pages 287-298.
Crossref
Christopher J Packard, Allan Gaw & James Shepherd. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Donald J. AbrahamMichael L. Sierra. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 339 383 .
Stephen D. Turley & John M. Dietschy. (2003) The Intestinal Absorption of Biliary and Dietary Cholesterol as a Drug Target for Lowering the Plasma Cholesterol Level. Preventive Cardiology 6:1, pages 29-64.
Crossref
Antonio M. GottoJrJr. (2002) Management of dyslipidemia. The American Journal of Medicine 112:8, pages 10-18.
Crossref
W W-L Wong, J Dimitroulakos, MD Minden & LZ Penn. (2002) HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 16:4, pages 508-519.
Crossref
Jim Dimitroulakos, Wilson H. Marhin, Jason Tokunaga, Jonathan Irish, Patrick Gullane, Linda Z. Penn & Suzanne Kamel-Reid. (2002) Microarray and Biochemical Analysis of Lovastatin-induced Apoptosis of Squamous Cell Carcinomas. Neoplasia 4:4, pages 337-346.
Crossref
Gilbert R. Thompson, Christopher J. Packard & Neil J. Stone. (2002) Goals of statin therapy: Three viewpoints. Current Atherosclerosis Reports 4:1, pages 26-33.
Crossref
Thierry Grand-Perret, Anne Bouillot, Aurélie Perrot, Stéphane Commans, Max Walker & Marc Issandou. (2001) SCAP ligands are potent new lipid-lowering drugs. Nature Medicine 7:12, pages 1332-1338.
Crossref
Margrit Schwarz, David W. Russell, John M. Dietschy & Stephen D. Turley. (2001) Alternate pathways of bile acid synthesis in the cholesterol 7α-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding. Journal of Lipid Research 42:10, pages 1594-1603.
Crossref
F. EzzetD. WexlerP. StatkevichT. KosoglouJ. PatrickL. LipkaL. MellarsE. VeltriV. Batra. (2013) The Plasma Concentration and LDL‐C Relationship in Patients Receiving Ezetimibe. The Journal of Clinical Pharmacology 41:9, pages 943-949.
Crossref
Farkad Ezzet, Gopal Krishna, David B. Wexler, Paul Statkevich, Teddy Kosoglou & Vijay K. Batra. (2001) A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe. Clinical Therapeutics 23:6, pages 871-885.
Crossref
Duane A. Burnett & Harry R. DavisJr.Jr.. 2001. 57 66 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.